AGM/EGMJun 11, 2026, 05:21 PM
Ocugen Stockholders Elect Directors, Ratify Auditor; Appoints CMO
AI Summary
Ocugen, Inc. held its 2026 Annual Meeting of Stockholders, where shareholders elected Kirsten Castillo, MBA, and Satish Chandran, Ph.D., as Class III Directors. They also ratified PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2026 and approved, on an advisory basis, the compensation of named executive officers, preferring an annual frequency for future advisory votes. Additionally, Mohamed Genead, M.D., M.Sc., was appointed Chief Medical Officer, effective June 11, 2026, after serving as Acting/Interim CMO.
Key Highlights
- Kirsten Castillo, MBA, elected Class III Director with 56,242,944 votes.
- Satish Chandran, Ph.D., elected Class III Director with 62,604,983 votes.
- PricewaterhouseCoopers LLP ratified as independent auditor with 136,784,245 votes.
- Stockholders approved executive officer compensation on an advisory basis with 49,968,948 votes.
- Annual frequency for future advisory votes on executive compensation approved with 57,545,540 votes.
- Mohamed Genead, M.D., M.Sc., appointed Chief Medical Officer, effective June 11, 2026.
Price Impact
More from OCGN